Concepedia

Céline Bonnefous

CB

20

Publications

1.9K

Citations

19

H-Index

1999

Active since

Affiliations

Edison Pharmaceuticals (United States)(Current)

General Atomics (United States)

University of Houston

Merck & Co., Inc., Rahway, NJ, USA (United States)

United States Military Academy

Céline Bonnefous is an author at Edison Pharmaceuticals (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1999–2018

20

Publications

20

ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Nicola J. Clegg, John Wongvipat, James D. Joseph et al. · Cancer Research · 2012 · 646 citations

Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts

Andiliy Lai, Mehmet Kahraman, Steven P. Govek et al. · Journal of Medicinal Chemistry · 2015 · 244 citations · Full text

, , +16

Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers

Terence G. Hamill, Stephen M. Krause, Christine Ryan et al. · Synapse · 2005 · 152 citations

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

James D. Joseph, Beatrice Darimont, Wei Zhou et al. · eLife · 2016 · 117 citations · Full text

, , +16

Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927

Mehmet Kahraman, Steven P. Govek, Johnny Nagasawa et al. · ACS Medicinal Chemistry Letters · 2018 · 74 citations · Full text

Rows per page

1–5 of 20